Chr. Hansen Overview
- Founded
-
1873
- Status
-
Public
- Employees
-
3,834
- Stock Symbol
-
CHR
- Investments
-
14
- Share Price
-
$74.36
- (As of Monday Closing)
Chr. Hansen General Information
Description
Founded in 1874 and relisted in 2010 after five years of private ownership, Chr. Hansen is a global bioscience company with more than 3,200 employees across 30 countries. Its segments include food cultures and enzymes that produce and sell innovative cultures, enzymes, and probiotic products that help determine the taste, flavor, texture, shelf-life, nutritional value, and health benefits of a variety of consumer products in the food industry, especially in the dairy industry; and health and nutrition that produce and sell products for the dietary supplement, over-the-counter pharmaceutical, infant formula, animal feed, and plant protection industries.
Contact Information
Website
www.chr-hansen.com
Ownership Status
Publicly Held
Financing Status
Pending Transaction (M&A)
Primary Industry
Biotechnology
Stock Exchange
CSE
Primary Office
- Boege Allé 10-12
- 2970 Hoersholm
- Denmark
+45 45 00 00 00
Chr. Hansen Stock Performance
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $74.36 | $74.32 | $46.99 - $85.42 | $9.8B | 132M | 183K | $1.84 |
Chr. Hansen Financials Summary
|
In Thousands, USD |
TTM 30-Nov-2022 | FY 2022 31-Aug-2022 | FY 2021 31-Aug-2021 | FY 2020 31-Aug-2020 |
|---|---|---|---|---|
| EV | 8,858,782 | 8,652,975 | 13,303,473 | 16,103,576 |
| Revenue | 1,331,170 | 1,336,728 | 1,287,570 | 1,079,817 |
| EBITDA | 326,952 | 461,599 | 451,618 | 421,574 |
| Net Income | 241,435 | 247,042 | 1,010,074 | 272,737 |
| Total Assets | 3,394,553 | 3,324,879 | 3,673,575 | 3,400,908 |
| Total Debt | 1,086,472 | 965,747 | 1,124,533 | 1,694,614 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Chr. Hansen Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Chr. Hansen Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Founded in 1874 and relisted in 2010 after five years of private ownership, Chr. Hansen is a global bioscience company w
Biotechnology
Hoersholm, Denmark
3,834
As of 2022
00000
00.00
0000-00-00
000000&0
00000
000000
re eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sun
0000000000000
Bagsvaerd, Denmark
0000
As of 0000
00000000
000000
te irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat
0000000000000
Mumbai, India
000
As of 0000
000.00
00000000000
000.00
Add Comparison
Chr. Hansen Competitors (10)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Novozymes | Corporation | Bagsvaerd, Denmark | 0000 | 00000000 | ||
| 00000000 000000 00 | Formerly PE-Backed | Mumbai, India | 000 | 000.00 | 00000000000 | 000.00 |
| 0000000 | Corporate Backed or Acquired | San Diego, CA | 00 | 000000000 - | ||
| 0000000 | Formerly VC-backed | New Brunswick, NJ | 00 | 00.00 | 000000&0 | 00.00 |
| 00-0000000 | Corporate Backed or Acquired | Saint Cugat Del Valles, Spain | 00 | 0000 | 000000&0 | 0000 |
Chr. Hansen Patents
Chr. Hansen Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2021299960-A1 | Production of dairy and dairy anologue products with pichia kluyveri yeast | Pending | 30-Jun-2020 | 00000000 | |
| CA-3173014-A1 | Method of reducing growth of listeria in food products | Pending | 16-Apr-2020 | 0000000000 | |
| EP-4135528-A1 | Method of reducing growth of listeria in food products | Pending | 16-Apr-2020 | 0000000000 | |
| CA-3173009-A1 | Listeria inhibition by manganese depletion | Pending | 16-Apr-2020 | 00000000 | |
| EP-4135526-A1 | Listeria inhibition by manganese depletion | Pending | 16-Apr-2020 | A23C3/00 |
Chr. Hansen Executive Team (18)
Chr. Hansen Board Members (15)
| Name | Representing | Role | Since |
|---|---|---|---|
| 000000 00000 | Chr. Hansen | Board Member | 000 0000 |
| 000000000 00000000 | Chr. Hansen | Board Member & Executive | 000 0000 |
| 000000000 00000000 | Self | Chairman & Board Member | 000 0000 |
| 00000 000000000-00 | Chr. Hansen | Board Member | 000 0000 |
| 000000 0000000000 | Chr. Hansen | Board Member & Vice Chairman | 000 0000 |
Chr. Hansen Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Chr. Hansen Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Chr. Hansen Investments & Acquisitions (14)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000000 000 | 09-Oct-2020 | 0000000000 | 00000 | Biotechnology | 00000000 |
| 000 000000000 | 27-Jul-2020 | 0000000000 | 00000 | Pharmaceuticals | 00000000 |
| 0000000 00000 | 20-Apr-2020 | 0000000000 | 00000 | Biotechnology | 00000000 |
| 00000000 | 02-Sep-2019 | 00000 0000 | Biotechnology | 00000000 | |
| LGG | 10-Nov-2016 | Merger/Acquisition | 000.00 | Biotechnology | 0000 00 0 |
Chr. Hansen ESG
Risk Overview
Risk Rating
Updated August, 04, 2022
15.29 | Low Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
00.0
Management
Management is related to actions taken to manage ESG issues
00.00
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
00 of 15,231
Rank
00.00
Percentile
Chemicals
Industry
0. of 540
Rank
0.00
Percentile
Specialty Chemicals
Subindustry
0. of 137
Rank
0.00
Percentile
Chr. Hansen Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 0-000 0000000 | 01-Feb-2008 | 0000000000 | Completed |
|